Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Administrator Search: 3 Obama-Era Officials Being Considered To Lead Biden’s Medicare Agency

Executive Summary

The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.

You may also be interested in...



As CMS Chief, Brooks-LaSure Could Turn Quickly To Medicare Drug Spending Reforms

Chiquita Brooks-LaSure would be in a key position to implement the Biden Administration’s drug pricing priorities and is familiar with the balancing act needed when considering competing interests among stakeholders as policies are shaped.

Woodcock Has Big, Quiet Supporter In Her Bid For US FDA Commissioner

Industry groups, along with many rare disease and patient advocacy groups, appear behind the acting commissioner getting the permanent position.

Digital Health Roundup, August/September 2021: Record Digital Health Funding Q1-3 Of $21.3Bn, AAOS Highlights, Regulatory Updates

In this roundup of developments in digital health, we highlight the key news and announcements from August and September.

Topics

UsernamePublicRestriction

Register

PS143682

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel